Erratum: Rationale, study design and implementation of the COLM study: the combination of OLMesartan and calcium channel blocker or diuretic in high-risk elderly hypertensive patients

Correction to: Hypertension Research (2009) 32, 163–167; doi:10.1038/hr.2008.31

During typesetting and correction of the above paper, incorrect affiliations were applied to the authors of the above paper and published as such. The publishers apologize for this and are now happy to correct this mistake—the correct affiliations are shown below:

Toshio Ogihara¹, Takao Saruta², Hiromi Rakugi¹, Kazuaki Shimamoto³, Sadayoshi Ito⁴, Hiroaki Matsuoka⁵, Masatsugu Horiuchi⁶, Tsutomu Imaizumi⁷, Shuichi Takishita⁸, Jitsuo Higaki⁶, Shigehiro Katayama⁹, Ikuo Saito² and Kazuyuki Shimada¹⁰, on behalf of the COLM study investigators

¹Osaka University Graduate School of Medicine, Osaka, Japan; ²Keio University, Tokyo, Japan; ³Sapporo Medical University School of Medicine, Sapporo, Japan; ⁴Tohoku University Graduate School of Medicine, Sendai, Japan; ⁵Dokkyo Medical University, Tochigi, Japan; ⁶Ehime University Graduate School of Medicine, Ehime, Japan; ⁷Kurume University School of Medicine, Kurume, Japan; ⁸University of the Ryukyus School of Medicine, Okinawa, Japan; ⁹Saitama Medical University, Saitama, Japan and ¹⁰Jichi Medical University, Shimotsuke, Japan